A Cohort Study of Chronic Cardiovascular Diseases

NCT04996342 | Unknown

• 1 other identifier: CVDcohort
• Study Type: observational
• Target: 10,000
• Locations: 1 country
• Sites: 1

Brief Summary

This prospective cohort study aims to establish cohorts of patients with chronic cardiovascular disease, including refractory and secondary hypertension, coronary heart disease, atrial fibrillation, ventricular arrhythmias, structural heart disease, pulmonary hypertension, heart failure and rare diseases of the cardiovascular system, and patients with implantations of cardiac pacemaker, in order to dynamically describe the population characteristics, diagnosis and treatment status and long-term prognosis and analyze the factors affecting the choice of treatment plan, long-term management quality and clinical prognosis of these patients.

Conditions

Cardiovascular Diseases; Cohort Studies

Outcome Measures

Primary Outcomes (1)

• Major Adverse Cardiovascular Events

  Time to the first occurence of Any cause death, myocardial infarction, or Stroke

  5 year

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients hospitalized in the department of Cardiology or outpatient department of Peking University First Hospital will be enrolled if they are aged ≥18 years old, meet the inclusion criteria of each cohort for the 9 specific chronic cardiovascular disease, and need long-term follow-up according to the judgment of doctors after informed consent. Patients will be included in different disease-specific cohorts based on the disease status and treatment, including hypertension, coronary heart disease, arrhythmia (atrial fibrillation, ventricular arrhythmia), pacemaker surgery, structural heart disease, and heart failure, etc. The same patient who meets the inclusion criteria of multiple specific diseases can be entered into different cohorts at the same time. It is expected to enroll 1500 to 2000 patients per year.

You may not qualify if:

• Refractory and secondary hypertension
• Patients diagnosed as refractory hypertension and/or secondary hypertension
• Patients willing to accept long-term follow-up and regular return visits
• Severe diseases of other systems may affecting the life span of patients
• Coronary heart disease
• Patients undergoing coronary angiography and interventional therapy in the cath lab
• Patients undergoing coronary angiography and functional assessment in the cath lab
• Patients diagnosed as acute myocardial infarction
• Severe diseases of other systems may affecting the life span of patients
• Regular return visits not available
• Atrial fibrillation
• PAtrial fibrillation diagnosed by electrocardiogram or holter (duration \>30 seconds)
• Patients willing to accept long-term follow-up and regular return visits
• Severe diseases of other systems may affecting the life span of patients
• New-onset atrial fibrillation during the perioperative period of major surgery

Sponsors & Collaborators

• Peking University First Hospital: lead

Study Sites (1)

Division of Cardiology, Peking University First Hospital

Beijing, Beijing Municipality, 100034, China

RECRUITING

MeSH Terms

Conditions

Cardiovascular Diseases

Central Study Contacts

Jia Jia

CONTACT

861083572283; jiajia9985@163.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director of Department of Cardiology

Study Record Dates

• First Submitted: August 2, 2021
• First Posted: August 9, 2021
• Study Start: April 15, 2021
• Primary Completion: December 1, 2025
• Study Completion: December 1, 2025
• Last Updated: August 9, 2021

Record last verified: 2021-08

Locations

CN (1)